Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.
Century Therapeutics has raised $135.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in January 2026.
Century Therapeutics's investors include RA Capital Management, Bain Capital Life Sciences, Fidelity, TCG Crossover, OrbiMed.
Century Therapeutics is headquartered in Philadelphia, United States.
Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.
Century Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Century Therapeutics — Funding & Investors." VCBacked, January 8, 2026, https://www.vcbacked.co/company/century-therapeutics. Accessed October 17, 2026.
VCBacked. (2026). Century Therapeutics — Funding & Investors. Retrieved October 17, 2026, from https://www.vcbacked.co/company/century-therapeutics
{{cite web |title=Century Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/century-therapeutics |website=VCBacked |access-date=October 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated